US Equity
CAMP
β CAMP4 THERAPEUTICS CORPORATIONCamp4 Therapeutics Corporation is a clinical-stage biopharmaceutical company developing RNA-targeting therapies for serious diseases.
π° Market cap: $177.59Mπ One Kendall Square, Bldg 1400 West 3rd Floor, CAMBRIDGE, MA, 02139 USπ·οΈ Biotechnology & Medical Researchπ΅ Previous close: $3.16π’ 9,756 credits left
Add Column
All
Trend
| Date βΎ | Close βΎ |
|---|---|
| 2026-07-24 | $3.16 |
| 2026-07-23 | $3.01 |
| 2026-07-22 | $3.11 |
| 2026-07-21 | $3.19 |
| 2026-07-20 | $3.32 |
| 2026-07-17 | $3.71 |
| 2026-07-16 | $3.90 |
| 2026-07-15 | $4.21 |
| 2026-07-14 | $4.45 |
| 2026-07-13 | $4.50 |
| 2026-07-10 | $4.33 |
| 2026-07-09 | $4.34 |
| 2026-07-08 | $4.19 |
| 2026-07-07 | $4.40 |
| 2026-07-06 | $4.28 |
| 2026-07-02 | $4.43 |
| 2026-07-01 | $4.34 |
| 2026-06-30 | $4.37 |
| 2026-06-29 | $4.44 |
| 2026-06-26 | $4.20 |
| 2026-06-25 | $3.92 |
| 2026-06-24 | $4.03 |
| 2026-06-23 | $4.36 |
| 2026-06-22 | $4.20 |
| 2026-06-18 | $4.13 |
| 2026-06-17 | $4.14 |
| 2026-06-16 | $4.13 |
| 2026-06-15 | $3.96 |
| 2026-06-12 | $4.19 |
| 2026-06-11 | $4.22 |
| 2026-06-10 | $4.34 |
| 2026-06-09 | $4.01 |
| 2026-06-08 | $4.09 |
| 2026-06-05 | $4.11 |
| 2026-06-04 | $4.30 |
| 2026-06-03 | $4.17 |
| 2026-06-02 | $3.98 |
| 2026-06-01 | $4.04 |
| 2026-05-29 | $4.39 |
| 2026-05-28 | $4.49 |
| 2026-05-27 | $4.21 |
| 2026-05-26 | $4.10 |
| 2026-05-22 | $4.51 |
| 2026-05-21 | $4.40 |
| 2026-05-20 | $4.50 |
| 2026-05-19 | $4.15 |
| 2026-05-18 | $4.56 |
| 2026-05-15 | $4.31 |
| 2026-05-14 | $4.38 |
| 2026-05-13 | $4.50 |
| 2026-05-12 | $4.50 |
| 2026-05-11 | $4.40 |
| 2026-05-08 | $4.46 |
| 2026-05-07 | $4.34 |
| 2026-05-06 | $4.06 |
| 2026-05-05 | $3.98 |
| 2026-05-04 | $3.86 |
| 2026-05-01 | $4.05 |
| 2026-04-30 | $4.17 |
| 2026-04-29 | $4.01 |
| 2026-04-28 | $4.27 |